• Selective Autophagy Regulates IRF3 Stability in Antiviral Im

  2026-07-21

  Wu et al. (2021) uncover a virus load-dependent mechanism by which selective autophagy, mediated through CALCOCO2/NDP52 and regulated by PSMD14 deubiquitinase activity, controls IRF3 degradation and thus fine-tunes type I interferon signaling. These findings clarify a crucial post-translational control node in innate immunity, with broad implications for the study of transcription factor regulation and immune homeostasis.

• Staurosporine in Tumor Microenvironment Research: A New Fron

  2026-07-20

  Explore how Staurosporine, a broad-spectrum serine/threonine protein kinase inhibitor, enables high-fidelity modeling of tumor microenvironment-driven apoptosis and angiogenesis in cancer research. This article delivers novel insights by connecting recent advances in ECM biology with practical assay design.

• Topotecan (SKF104864): Optimized Workflows for Cancer Resear

  2026-07-20

  Topotecan (SKF104864) empowers cancer researchers with reproducible, high-impact protocols for apoptosis induction in glioma cells and pediatric tumor models. This comprehensive guide distills experimental best practices, troubleshooting strategies, and the latest evidence to help you unlock the full potential of APExBIO's Topotecan in translational oncology.

• Sulfo-NHS-Biotin: Rethinking Precision in Translational Prot

  2026-07-19

  This thought-leadership article explores the mechanistic and translational impact of Sulfo-NHS-Biotin, emphasizing its unique chemistry, experimental advantages, and strategic considerations for researchers aiming to advance protein-based therapeutics. Integrating evidence from recent advances in site-specific biotinylation and high-throughput screening, we position APExBIO's offering as a pivotal tool for next-generation cell surface protein labeling, while offering a forward-looking perspective on the future of biotinylation in translational science.

• SARS-CoV-2 Nucleocapsid Protein Inhibits GADD34-Mediated Imm

  2026-07-18

  This study uncovers how the SARS-CoV-2 nucleocapsid protein antagonizes the GADD34-mediated innate immune pathway by promoting the sequestration of GADD34 mRNA into atypical stress granule-like foci. These findings clarify a novel mechanism of viral immune evasion with implications for understanding viral pathogenesis and designing targeted antiviral strategies.

• Gap26 Connexin 43 Mimetic Peptide: Protocols & Troubleshooti

  2026-07-17

  Gap26 enables precise, reproducible modulation of gap junction signaling in neurovascular and pain research. Discover how this connexin 43 mimetic peptide streamlines experimental workflows and offers actionable troubleshooting, with validated results in advanced neuroprotection and vascular models.

• BFH772 (VEGFR2 inhibitor): Technical Guide for Angiogenesis

  2026-07-17

  BFH772 is a small-molecule VEGFR2 inhibitor designed for selective suppression of VEGFR2-mediated angiogenesis, especially in tumor model research. It is best suited for workflows demanding high kinase selectivity and solubility in organic solvents, and is not recommended for applications needing water-soluble compounds or broad kinase inhibition.

• Firefly Luciferase mRNA (ARCA, 5-moUTP): Modernizing Reporte

  2026-07-16

  Explore how Firefly Luciferase mRNA (ARCA, 5-moUTP) elevates bioluminescent reporter assays with advanced capping and nucleotide modifications. This article uniquely connects recent mRNA loading breakthroughs with practical assay optimization, offering researchers actionable insights.

• THZ1 and the Future of Covalent CDK7 Inhibition in Cancer Re

  2026-07-16

  This article provides a thought-leadership perspective on the strategic deployment of THZ1, a covalent CDK7 inhibitor, in translational cancer research. It delves into the mechanistic foundations of covalent CDK7 targeting, evaluates emerging resistance mechanisms, addresses experimental design best practices, and charts a vision for leveraging THZ1 in the evolving landscape of cancer biology. Special attention is given to the translational promise in T-ALL research and the importance of protocol rigor for maximizing biological insight.

• GPR107 Loss Drives Collagen IV Accumulation in Diabetic Neph

  2026-07-15

  Xu et al. reveal that G protein-coupled receptor 107 (GPR107) deficiency exacerbates diabetic nephropathy by disrupting collagen IV homeostasis in podocytes. Their findings link impaired GPR107-mediated endocytosis to enhanced AT1R/Ca2+ signaling and offer new insight into potential therapeutic targets for renal fibrosis.

• Phenothiazines Boost Macrophage Antibacterial Action via ROS

  2026-07-15

  The referenced study reveals that phenothiazines, including perphenazine, significantly enhance macrophage antibacterial defense by inducing both reactive oxygen species (ROS) production and autophagy. These findings suggest new host-directed strategies to address intracellular bacterial infections, offering a potential path to overcome antibiotic resistance.

• NU7441 (KU-57788): Precision DNA-PK Inhibition in Oncology

  2026-07-14

  NU7441 (KU-57788) offers nanomolar-range, highly selective DNA-PK inhibition, enabling robust DNA repair and oncology research. Its combination of specificity, workflow flexibility, and translational relevance—exemplified by its role in dissecting immune escape in gastric cancer—distinguishes it as a cornerstone compound for advancing cell cycle and DNA damage studies.

• Fra2/LCN2 Axis Drives PM2.5-Linked Asthma via Macrophage Fer

  2026-07-14

  This study identifies the Fra2/LCN2 pathway as a critical mechanism linking PM2.5 exposure to asthma exacerbation through induction of ferroptosis in M2 macrophages. Targeted disruption of this pathway mitigates airway inflammation and dysfunction, offering a new therapeutic angle for environment-associated asthma and advancing our understanding of iron metabolism in immune cells.

• Cell lysis buffer for WB and IP: Precision Protein Extractio

  2026-07-13

  Cell lysis buffer for WB and IP enables efficient, non-denaturing protein extraction for Western blot and immunoprecipitation. Its optimized inhibitor cocktail preserves protein interactions, minimizing degradation and supporting robust tumor microenvironment proteomics.

• WST-8 Glucose Uptake Assay Kit: Precision Metabolic Profilin

  2026-07-13

  Explore the WST-8 Glucose Uptake Assay Kit for highly sensitive, non-radioactive quantification of cellular glucose uptake. This article reveals advanced scientific insights, including ion supplementation strategies, and positions the kit as a cornerstone technology for metabolic research.

441 records 10/30 page Previous Next First page 上5页 678910 下5页 Last page